This white paper seeks to give an overview on medication adherence, examining the financial costs of non-adherence and analyzing the importance of real-world adherence data for maximizing the commercial value of a product.
In a healthcare economy that is under pressure to provide cost savings, biopharma must demonstrate a long-term commitment to supporting health systems through effective adherence support programs. A patient-centric approach that includes education and emotional support is vital to improve adherence, and the expertise and knowledge provided by nurse educators (NEs) is fundamental for biopharma. Advances in technology and the digitization of patient services can also support the delivery of a patient-centric approach that empowers patients to make informed decisions about their healthcare. By uniting with multiple stakeholders to deliver cohesive and effective adherence support programs, biopharma can help to sustain the NHS at a local level.